PL2649068T3 - Pochodne eteru oksazolilowo-metylowego jako agoniści receptora ALX - Google Patents
Pochodne eteru oksazolilowo-metylowego jako agoniści receptora ALXInfo
- Publication number
- PL2649068T3 PL2649068T3 PL11804810T PL11804810T PL2649068T3 PL 2649068 T3 PL2649068 T3 PL 2649068T3 PL 11804810 T PL11804810 T PL 11804810T PL 11804810 T PL11804810 T PL 11804810T PL 2649068 T3 PL2649068 T3 PL 2649068T3
- Authority
- PL
- Poland
- Prior art keywords
- oxazolyl
- receptor agonists
- alx receptor
- methylether derivatives
- methylether
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- AIDS & HIV (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2010055616 | 2010-12-07 | ||
| PCT/IB2011/055487 WO2012077049A1 (en) | 2010-12-07 | 2011-12-06 | Oxazolyl-methylether derivatives as alx receptor agonists |
| EP11804810.7A EP2649068B1 (en) | 2010-12-07 | 2011-12-06 | Oxazolyl-methylether derivatives as alx receptor agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2649068T3 true PL2649068T3 (pl) | 2015-03-31 |
Family
ID=45444667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11804810T PL2649068T3 (pl) | 2010-12-07 | 2011-12-06 | Pochodne eteru oksazolilowo-metylowego jako agoniści receptora ALX |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8846733B2 (pl) |
| EP (1) | EP2649068B1 (pl) |
| JP (1) | JP5923107B2 (pl) |
| KR (1) | KR101864463B1 (pl) |
| CN (1) | CN103261194B (pl) |
| AR (1) | AR084173A1 (pl) |
| AU (1) | AU2011340146B2 (pl) |
| CA (1) | CA2816376C (pl) |
| CY (1) | CY1116004T1 (pl) |
| DK (1) | DK2649068T3 (pl) |
| ES (1) | ES2526132T3 (pl) |
| HR (1) | HRP20150049T1 (pl) |
| MX (1) | MX2013006418A (pl) |
| PL (1) | PL2649068T3 (pl) |
| PT (1) | PT2649068E (pl) |
| RU (1) | RU2588567C2 (pl) |
| SI (1) | SI2649068T1 (pl) |
| TW (1) | TWI523853B (pl) |
| WO (1) | WO2012077049A1 (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2814826C (en) | 2010-11-17 | 2019-02-12 | Actelion Pharmaceuticals Ltd | Bridged spiro[2.4]heptane ester derivatives |
| WO2013171687A1 (en) | 2012-05-16 | 2013-11-21 | Actelion Pharmaceuticals Ltd | 1-(p-tolyl)cyclopropyl substituted bridged spiro[2.4]heptane derivatives as alx receptor agonists |
| MA37618B1 (fr) | 2012-05-16 | 2017-08-31 | Actelion Pharmaceuticals Ltd | Dérivés pontés fluorés de spiro[2.4]heptane en tant qu'agonistes de récepteur alx |
| AR096686A1 (es) | 2013-06-25 | 2016-01-27 | Actelion Pharmaceuticals Ltd | Derivados de espiro[2.4]heptano puenteados sustituidos con difluoroetil-oxazol como agonistas del receptor de alx |
| ES2639798T3 (es) | 2013-07-18 | 2017-10-30 | Idorsia Pharmaceuticals Ltd | Derivados de espiro[2.4]heptano con puente sustituidos con piperazina como agonistas del receptor ALX |
| AR097279A1 (es) | 2013-08-09 | 2016-03-02 | Actelion Pharmaceuticals Ltd | Derivados de benzimidazolil-metil urea como agonistas del receptor de alx |
| NZ752095A (en) | 2013-11-28 | 2022-07-01 | Kyorin Seiyaku Kk | Urea derivative or pharmacologically acceptable salt thereof |
| US10525058B2 (en) | 2015-05-27 | 2020-01-07 | Kyorin Pharmaceutical Co., Ltd | Urea derivative or pharmacologically acceptable salt thereof |
| US10858314B2 (en) | 2015-05-27 | 2020-12-08 | Kyorin Pharmaceutical Co., Ltd. | Urea derivative or pharmacologically acceptable salt thereof |
| US11439615B2 (en) | 2017-03-09 | 2022-09-13 | University Health Network | Lipoxin and lipoxin analogue mediated neuroprotection and treatments |
| SG11202008504SA (en) | 2018-03-05 | 2020-10-29 | Bristol Myers Squibb Co | Phenylpyrrolidinone formyl peptide 2 receptor agonists |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62234018A (ja) | 1986-04-02 | 1987-10-14 | Rooto Seiyaku Kk | 糖尿病併発症治療剤 |
| US20040043904A1 (en) | 2000-09-22 | 2004-03-04 | Hiroshi Yamaguchi | N-(4-pyrazolyl) amide derivatives, chemicals for agricultural and horticultural use, and usage of the same |
| EP1492552A2 (en) | 2002-04-03 | 2005-01-05 | Bayer Aktiengesellschaft | Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| EP1692502A2 (en) | 2003-11-07 | 2006-08-23 | Acadia Pharmaceuticals Inc. | Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| AU2005247473A1 (en) * | 2004-05-25 | 2005-12-08 | Metabolex, Inc. | Substituted triazoles as modulators of PPAR and methods of their preparation |
| US8026260B2 (en) | 2005-11-03 | 2011-09-27 | Merck Sharp & Dohme Corp. | Histone deacetylase inhibitors with aryl-pyrazolyl-motifs |
| ES2545121T3 (es) | 2007-08-21 | 2015-09-08 | Senomyx, Inc. | Compuestos que inhiben (bloquean) el sabor amargo en composiciones, y uso de los mismos |
| AR069650A1 (es) | 2007-12-14 | 2010-02-10 | Actelion Pharmaceuticals Ltd | Derivados de aminopirazol como agonistas no peptidicos del receptor alx humano |
| DK2225231T3 (da) * | 2007-12-18 | 2011-10-17 | Actelion Pharmaceuticals Ltd | Aminotriazolderivater som alx-agonister |
| KR101724765B1 (ko) | 2009-05-18 | 2017-04-07 | 액테리온 파마슈티칼 리미티드 | Ａｌｘ 수용체 및/또는 ｆｐｒｌ2 아고니스트로서의 브릿지 스피로［2.4］헵탄 유도체 |
| CN101909306A (zh) * | 2009-06-08 | 2010-12-08 | 中兴通讯股份有限公司 | 中继站管理方法及基站 |
| JP5095035B2 (ja) * | 2009-06-09 | 2012-12-12 | アクテリオン ファーマシューティカルズ リミテッド | フッ素化アミノトリアゾール誘導体 |
| US8674111B2 (en) | 2009-06-12 | 2014-03-18 | Actelion Pharmaceuticals Ltd. | Oxazole and thiazole derivatives as ALX receptor agonists |
| JP2012254939A (ja) * | 2009-10-07 | 2012-12-27 | Astellas Pharma Inc | オキサゾール化合物 |
-
2011
- 2011-12-06 CA CA2816376A patent/CA2816376C/en not_active Expired - Fee Related
- 2011-12-06 KR KR1020137017686A patent/KR101864463B1/ko not_active Expired - Fee Related
- 2011-12-06 PL PL11804810T patent/PL2649068T3/pl unknown
- 2011-12-06 DK DK11804810.7T patent/DK2649068T3/en active
- 2011-12-06 AR ARP110104559A patent/AR084173A1/es unknown
- 2011-12-06 CN CN201180058458.7A patent/CN103261194B/zh not_active Expired - Fee Related
- 2011-12-06 ES ES11804810.7T patent/ES2526132T3/es active Active
- 2011-12-06 MX MX2013006418A patent/MX2013006418A/es active IP Right Grant
- 2011-12-06 WO PCT/IB2011/055487 patent/WO2012077049A1/en not_active Ceased
- 2011-12-06 EP EP11804810.7A patent/EP2649068B1/en not_active Not-in-force
- 2011-12-06 HR HRP20150049AT patent/HRP20150049T1/hr unknown
- 2011-12-06 RU RU2013130879/04A patent/RU2588567C2/ru not_active IP Right Cessation
- 2011-12-06 JP JP2013542652A patent/JP5923107B2/ja not_active Expired - Fee Related
- 2011-12-06 SI SI201130348T patent/SI2649068T1/sl unknown
- 2011-12-06 AU AU2011340146A patent/AU2011340146B2/en not_active Ceased
- 2011-12-06 PT PT118048107T patent/PT2649068E/pt unknown
- 2011-12-06 US US13/992,143 patent/US8846733B2/en not_active Expired - Fee Related
- 2011-12-06 TW TW100144916A patent/TWI523853B/zh not_active IP Right Cessation
-
2015
- 2015-01-23 CY CY20151100075T patent/CY1116004T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK2649068T3 (en) | 2014-12-08 |
| HRP20150049T1 (hr) | 2015-02-27 |
| AR084173A1 (es) | 2013-04-24 |
| TW201305151A (zh) | 2013-02-01 |
| KR101864463B1 (ko) | 2018-06-04 |
| KR20130133240A (ko) | 2013-12-06 |
| TWI523853B (zh) | 2016-03-01 |
| MX2013006418A (es) | 2013-07-15 |
| EP2649068A1 (en) | 2013-10-16 |
| JP2013544878A (ja) | 2013-12-19 |
| SI2649068T1 (sl) | 2015-01-30 |
| CA2816376C (en) | 2018-11-20 |
| PT2649068E (pt) | 2014-12-23 |
| WO2012077049A1 (en) | 2012-06-14 |
| US20130261159A1 (en) | 2013-10-03 |
| AU2011340146B2 (en) | 2016-05-19 |
| JP5923107B2 (ja) | 2016-05-24 |
| CN103261194B (zh) | 2016-02-24 |
| US8846733B2 (en) | 2014-09-30 |
| CY1116004T1 (el) | 2017-01-25 |
| ES2526132T3 (es) | 2015-01-07 |
| CN103261194A (zh) | 2013-08-21 |
| RU2013130879A (ru) | 2015-01-20 |
| EP2649068B1 (en) | 2014-10-29 |
| AU2011340146A1 (en) | 2013-07-25 |
| RU2588567C2 (ru) | 2016-07-10 |
| CA2816376A1 (en) | 2012-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2649068T1 (sl) | Derivati oksazolil-metiletra kot agonisti alx-receptorja | |
| IL222646A0 (en) | N3-substituted -n1-sulfonyl-5-fluoropyrimidinone derivatives | |
| ZA201208447B (en) | Indoles | |
| EP2646020A4 (en) | INDOLES | |
| ZA201209117B (en) | Tetrahydro-pyrido-pyrimidine derivatives | |
| GB201410398D0 (en) | Muscarinic m1 receptor agonists | |
| IL229320A0 (en) | History of 3-spirocyclic piperidines as ghrelin receptor agonists | |
| EP2569324A4 (en) | Aminoglycoside DERIVATIVES | |
| GB2490849B (en) | Di-aspirin derivatives | |
| HUP1000243A2 (en) | 8-hidroxy-quinoline derivatives | |
| IL225393A0 (en) | History of Indole | |
| GB201116152D0 (en) | Cannabinoid-2-receptor agonists | |
| GB2485874B (en) | Beam hanger | |
| TWM387187U (en) | Monitor hanging structure | |
| GB201116151D0 (en) | Cannabinoid-2-receptor agonists | |
| ZA201209248B (en) | Amido-tropane derivatives | |
| IL220983A0 (en) | 2-aldoximino-5-fluoropyrimidine derivatives | |
| GB201004821D0 (en) | Cylinder pivoting device | |
| HK1186116A (en) | Microcrystalline y receptor agonists | |
| TWM402665U (en) | Improved structure for hanger | |
| TWM385717U (en) | Monitor adjustment structure | |
| GB201021329D0 (en) | Early breakout | |
| GB201000547D0 (en) | Jurasic |